2021-07-07T07:10:22-05:00 2020-12-31 410746749 CLIFTONLARSONALLEN LLP 610 W GERMANTOWN PIKE SUITE 400 PLYMOUTH MEETING PA 19462 990 2020-01-01 223369741 INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS OUTCOMES RESEARCH INTE 6095864981 505 LAWRENCE SQUARE BLVD SOUTH LAWRENCEVILLE NJ 08648 MS NANCY S BERG CEO & EXECUTIVE DIRECTOR 6095864981 2021-07-06 1 MS NANCY S BERG 999009999 WILLIAM A LOUGHERY P01603932 2156433900 2021-07-06 2 AAL1 IAL1 2020 2022-09-23 18:48:47Z MS NANCY S BERG 505 LAWRENCE SQUARE BLVD SOUTH LAWRENCEVILLE NJ 08648 23696317 0 X WWW.ISPOR.ORG X 1995 NJ PROMOTE HEALTH ECONOMICS AND OUTCOMES RESEARCH EXCELLENCE TO IMPROVE DECISION MAKING FOR HEALTH GLOBALLY 12 11 56 750 11300 2381 210000 105000 15953983 4613194 347895 145986 47948 9298233 16559826 14162413 0 0 0 0 6404867 6014786 0 0 0 8709738 3398368 15114605 9413154 1445221 4749259 20352941 26278189 2402976 2608877 17949965 23669312 X THE MISSION OF INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS OUTCOMES RESEARCH (ISPOR) IS TO PROMOTE HEALTH ECONOMICS AND OUTCOMES RESEARCH EXCELLENCE TO IMPROVE DECISION MAKING FOR HEALTH GLOBALLY. 0 0 7340210 0 4601894 ISPOR IS A NON-PROFIT GLOBAL SCIENTIFIC AND EDUCATIONAL ORGANIZATION WITH APPROXIMATELY 6,080 MEMBERS, WHO ARE INVOLVED IN HEALTHCARE OUTCOMES RESEARCH (INCLUDING CLINICAL, ECONOMIC AND PATIENT-REPORTED OUTCOMES) OF HEALTH TECHNOLOGIES (DRUGS, DEVICES, DIAGNOSTICS) AND SERVICES OR THE USE OF OUTCOMES RESEARCH IN HEALTHCARE DECISIONS. THE MISSION OF ISPOR IS TO PROMOTE HEALTH ECONOMICS AND OUTCOMES RESEARCH EXCELLENCE TO IMPROVE DECISION MAKING FOR HEALTH GLOBALLY. ISPOR IS FUNDED THROUGH ITS MEETINGS, TRAINING COURSES AND MEMBERSHIP DUES. THROUGH ITS MULTIPLE MEETINGS EACH YEAR, ISPOR PROVIDES A FORUM TO FACILITATE THE INTERCHANGE OF SCIENTIFIC KNOWLEDGE IN PHARMACOECONOMICS /HEALTH ECONOMICS AND OUTCOMES RESEARCH, HEALTH POLICY AND THE USE OF THIS RESEARCH IN HEALTHCARE DECISIONS.ISPOR PUBLISHES TWO SCIENTIFIC JOURNALS, ONE TECHNICAL AND NEWS JOURNAL, AND FOUR ELECTRONIC NEWSLETTERS. ISPOR DEVELOPS CONSENSUS DOCUMENTS (GOOD PRACTICES/GUIDELINES) ON OUTCOMES RESEARCH METHODS OR USE OF THIS RESEARCH IN HEALTHCARE DECISIONS. ISPOR FOSTERS EDUCATION AND THE DEVELOPMENT OF OUTCOMES RESEARCH AT THE LOCAL LEVEL WITH ITS REGIONAL CHAPTERS AND STUDENT CHAPTERS GLOBALLY TO PROMOTE THE SCIENCE OF PHARMACOECONOMICS/HEALTH ECONOMICS AND HEALTH OUTCOMES RESEARCH WORLDWIDE. IN 2020 ISPOR HELD THREE VIRTUAL CONFERENCES (NORTH AMERICAN, ASIA PACIFIC, EUROPEAN) INCLUDING 5,400 SCIENTIFIC PRESENTATIONS WITH OVER 5,000 PARTICIPANTS. IN 2020, ISPOR PUBLISHED 3,356 PAGES OF OUTCOMES RESEARCH AND HEALTH POLICY PAPERS IN ITS THREE JOURNALS: VALUE IN HEALTH, VALUE IN HEALTH REGIONAL ISSUES AND VALUE AND OUTCOMES SPOTLIGHT. IN 2020 ISPOR HAD OVER 6,080 MEMBERS FROM 110 COUNTRIES, 136 STUDENTS AND OVER 88 REGIONAL CHAPTERS AROUND THE WORLD. THROUGH ISPOR TASK FORCES, COUNCILS AND SPECIAL INTEREST GROUPS, ISPOR HAS DEVELOPED 'TOOLS' FOR OUTCOMES RESEARCHERS, SUCH AS GOOD PRACTICES FOR OUTCOMES RESEARCH WITH OVER 1,000,000 DOWNLOADS ANNUALLY AND A WEB-BASED DATABASE OF OVER 54,000 RESEARCH PRESENTATIONS GIVEN AT ISPOR MEETINGS. 7340210 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 49 0 56 1 1 1 0 0 0 0 0 0 0 0 0 0 0 X 12 11 0 0 1 0 1 1 0 1 1 0 1 1 0 1 1 1 1 1 1 0 0 NJ X KEVIN DOLAN 6095864981 505 LAWRENCE SQUARE BLVD SOUTH LAWRENCEVILLE NJ 08648 NANCY S BERG CEO & EXECUTIVE DIRECTOR 40.00 X X 579231 0 55327 JENS GRUEGER PRESIDENT - EFFECTIVE JULY 2020 2.00 X X 0 0 0 ISAO KAME DRPH MD PRESIDENT ELECT 2.00 X X 0 0 0 FEDERICO AUGUSTOVSKI PAST PRESIDENT 2.00 X X 0 0 0 SHELBY D REED PAST PRESIDENT 2.00 X X 0 0 0 SEAN SULLIVAN TREASURER - EFFECTIVE MAY 2020 2.00 X X 0 0 0 KALIPSO CHALKIDOU MD PHD DIRECTOR 2.00 X 0 0 0 JALPA DOSHI DIRECTOR 2.00 X 0 0 0 RAOH-FANG PWU DIRECTOR 2.00 X 0 0 0 NEIL HAWKINS DIRECTOR 2.00 X 0 0 0 ROK HREN DIRECTOR 2.00 X 0 0 0 EBERECHUKWU ONUKWUGHA PHD DIRECTOR 2.00 X 0 0 0 DAVID THOMPSON PHD DIRECTOR 2.00 X 0 0 0 NANCY DEVLIN ACTING PRESIDENT - TERM ENDED JUNE 2020 2.00 X X 0 0 0 ZEBA M KHAN TREASURER - TERM ENDED MAY 2020 2.00 X X 0 0 0 MEINDERT BOYSEN DIRECTOR - TERM ENDED JUNE 2020 2.00 X 0 0 0 STEPHANIE EARNSHAW DIRECTOR - TERM ENDED JUNE 2020 2.00 X 0 0 0 JAN ELIAS HANSEN DIRECTOR - TERM ENDED JUNE 2020 2.00 X 0 0 0 JOHN WATKINS DIRECTOR - TERM ENDED JUNE 2020 2.00 X 0 0 0 KEVIN DOLAN DIRECTOR, FINANCE 40.00 X 151078 0 15084 SUSAN CAPON CHIEF OPERATING OFFICER 40.00 X 284208 0 36745 LUCINDA ORSINI ASSOCIATE CHIEF SCIENCE OFFICER 40.00 X 321001 0 25559 JULIE MCGRATH SENIOR DIRECTOR, GLOBAL EVENTS 40.00 X 183831 0 20234 ELIZABETH LANE CHIEF MARKETING OFFICER 40.00 X 174805 0 28796 CHRISTINA DARNOWSKI DIRECTOR, GOVERNANCE 40.00 X 152514 0 25045 JENNIFER OLSEN-CASILLAS DIRECTOR, MEMBER SERVICES 40.00 X 144210 0 29742 1990878 0 236532 8 0 1 0 ELSEVIER INC PO BOX 9533 NEW YORK NY 100879533 PUBLISHING 538829 RICHARD J WILLKE 11622 CHANNEL FRONT COURT SODDY DAISY TN 37379 SCIENTIFIC CONSULTING 363235 STELLALIANCE SUNDHOLMSGATAN 9 MALMO SW 21128 SCIENTIFIC CONSULTING 233966 AUSTRIA CENTER VIENNA BRUNO-KREISKY-PLATZ 1 WIEN AU 1220 CONFERENCE SERVICES 189445 FIERA MILANO CONGRESSI SPA PIAZZALE CARLO MAGNO MILANO IT 20149 CONFERENCE SERVICES 162428 6 105000 105000 EBULLETIN/TECH JOURNAL REVENUE 541900 1270369 1259069 11300 ANNUAL EUROPEAN MEETING 611430 1247251 1247251 MEMBER SERVICES 611430 902326 902326 ANNUAL AND VIRTUAL MEETINGS 611430 490935 490935 EDUCATION AND SCIENTIFIC REVENUE 541900 479973 479973 222340 222340 4613194 322828 322828 75769 20740 55029 55029 55029 9336322 9513164 -176842 -176842 -176842 INSURANCE PROCEEDS 900099 9243204 9243204 9243204 14162413 4601894 11300 9444219 1121673 405458 716215 3803242 3151677 651565 252387 216771 35616 494997 370964 124033 342487 250262 92225 22807 22807 31463 31463 97484 97484 717098 706153 10945 385003 281330 103673 75457 55138 20319 390386 390386 233596 170693 62903 41696 30468 11228 JOURNAL/EDITORIAL 812502 812502 BOARD/COMMITTEE EXPENSE 215228 211080 4148 BANK/CREDIT CARD FEES 125269 91537 33732 COMMUNICATION 93425 68268 25157 156954 127523 29431 9413154 7340210 2072944 0 884582 1430993 2262063 593941 691778 6944301 397565 490530 4183212 1021955 3320144 3161257 12796809 13657167 20352941 26278189 574175 371900 1806410 1213686 1015900 22391 7391 2402976 2608877 X 17949965 23669312 17949965 23669312 20352941 26278189 4749259 970088 0 X 0 1 X 1 0 X 786327 912462 904564 210000 105000 2918353 11578131 13823398 14730663 15903323 4601894 60637409 12364458 14735860 15635227 16113323 4706894 63555762 0 0 0 63555762 317484 306961 341347 402812 398597 1767201 317484 306961 341347 402812 398597 1767201 97279 66192 10586 7372 2381 183810 9243204 9243204 12779221 15109013 15987160 16523507 14351076 74749977 0.85020 0.97420 0.02360 0.02320 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: INSURANCE PROCEEDS - 2020 AMOUNT: $ 9,243,204. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 400000 400000 2535060 535935 1999125 1248152 486020 762132 3161257 SECURITY DEPOSIT 7391 7391 X 15035017 970088 970088 14064929 97484 97484 14162413 9315670 0 9315670 97484 97484 9413154 PART X, LINE 2: ISPOR IS EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE (IRC). HOWEVER, INCOME FROM CERTAIN ACTIVITIES NOT DIRECTLY RELATED TO ISPOR'S TAX-EXEMPT PURPOSE IS SUBJECT TO TAXATION AS UNRELATED BUSINESS INCOME. ISPOR FOLLOWS THE INCOME TAX STANDARD FOR UNCERTAIN TAX POSITIONS. ISPOR BELIEVES THERE ARE NO UNCERTAIN TAX POSITIONS THAT ARE REQUIRED TO BE DISCLOSED IN THE FINANCIAL STATEMENTS. X X X X X 0 0 0 0 0 0 0 1 0 NANCY S BERG CEO & EXECUTIVE DIRECTOR 579231 0 0 0 0 0 42750 0 12577 0 634558 0 0 0 LUCINDA ORSINI ASSOCIATE CHIEF SCIENCE OFFICER 268661 0 52340 0 0 0 13547 0 12012 0 346560 0 0 0 SUSAN CAPON CHIEF OPERATING OFFICER 236508 0 47700 0 0 0 25742 0 11003 0 320953 0 0 0 JULIE MCGRATH SENIOR DIRECTOR, GLOBAL EVENTS 169831 0 14000 0 0 0 8222 0 12012 0 204065 0 0 0 ELIZABETH LANE CHIEF MARKETING OFFICER 166908 0 7897 0 0 0 16784 0 12012 0 203601 0 0 0 CHRISTINA DARNOWSKI DIRECTOR, GOVERNANCE 144769 0 7745 0 0 0 16036 0 9009 0 177559 0 0 0 JENNIFER OLSEN-CASILLAS DIRECTOR, MEMBER SERVICES 134610 0 9600 0 0 0 14142 0 15600 0 173952 0 0 0 KEVIN DOLAN DIRECTOR, FINANCE 130419 0 20659 0 0 0 14208 0 876 0 166162 0 0 0 PART I, LINE 7 THE BONUSES WERE PART OF THE ANNUAL BUDGET WHICH WAS APPROVED BY THE BOARD OF DIRECTORS. THESE AMOUNTS ARE INCLUDED IN EACH RECIPIENT'S 2020 FORM W-2. THE FOLLOWING EMPLOYEES RECEIVED BONUSES IN 2020: LUCINDA ORSINI: $52,340 DISCRETIONARY BONUS BASED ON PERSONAL PERFORMANCE AND SUBJECT TO APPROVAL BY THE CEO & EXECUTIVE DIRECTOR. SUSAN CAPON: $47,700 DISCRETIONARY BONUS BASED ON PERSONAL PERFORMANCE AND SUBJECT TO APPROVAL BY THE CEO & EXECUTIVE DIRECTOR. JULIE MCGRATH: $14,000 DISCRETIONARY BONUS BASED ON PERSONAL PERFORMANCE AND SUBJECT TO APPROVAL BY THE CEO & EXECUTIVE DIRECTOR. ELIZABETH LANE: $7,897 DISCRETIONARY BONUS BASED ON PERSONAL PERFORMANCE AND SUBJECT TO APPROVAL BY THE CEO & EXECUTIVE DIRECTOR. CHRISTINA DARNOWSKI: $7,745 DISCRETIONARY BONUS BASED ON PERSONAL PERFORMANCE AND SUBJECT TO APPROVAL BY THE CEO & EXECUTIVE DIRECTOR. JENNIFER OLSEN-CASILLAS: $9,600 DISCRETIONARY BONUS BASED ON PERSONAL PERFORMANCE AND SUBJECT TO APPROVAL BY THE CEO & EXECUTIVE DIRECTOR. KEVIN DOLAN: $20,659 DISCRETIONARY BONUS BASED ON PERSONAL PERFORMANCE AND SUBJECT TO APPROVAL BY THE CEO & EXECUTIVE DIRECTOR. FORM 990, PART VI, SECTION A, LINE 1 THE EXECUTIVE COMMITTEE HAS THE DUTIES AND AUTHORITY BETWEEN MEETINGS OF THE BOARD, IN PLACE OF THE BOARD, TO TAKE ACTION ON MATTERS CONSISTENT WITH THE GOALS OF THE SOCIETY. THE EXECUTIVE COMMITTEE IS COMPRISED OF THE OFFICERS OF THE SOCIETY: PRESIDENT, IMMEDIATE PAST PRESIDENT, PRESIDENT-ELECT, EXECUTIVE DIRECTOR (AS SECRETARY) AND TREASURER. THE EXECUTIVE DIRECTOR IS A VOTING MEMBER OF THE BOARD, EXCEPT ON THE MATTER OF THE EXECUTIVE DIRECTOR'S SALARY AND CONTRACT REVIEW AND DETERMINATION. FORM 990, PART VI, SECTION A, LINE 4 TWO NEW CLASSES OF MEMBERS WITH VOTING RIGHTS HAVE BEEN ADDED TO THE GOVERNING DOCUMENTS OF THE ORGANIZATION, NEW PROFESSIONALS AND RETIRED MEMBERS. FORM 990, PART VI, SECTION A, LINE 6 THE SOCIETY HAS FIVE TYPES OF MEMBERS AS FOLLOWS: MEMBER - ANY INDIVIDUAL WHO SUPPORTS THE OBJECTIVES OF THE SOCIETY AND IS WILLING TO CONTRIBUTE TO THE ACHIEVEMENT OF THOSE OBJECTIVES IS ELIGIBLE FOR MEMBERSHIP. STUDENT MEMBER - ANY INDIVIDUAL FORMALLY ENROLLED IN A PROGRAM OF STUDY WHICH INCLUDES ASPECTS OF HEALTH ECONOMICS OR HEALTH OUTCOMES RESEARCH IN THE STUDY CURRICULUM AND SUPPORTS THE MISSION OF THE SOCIETY IS ELIGIBLE FOR STUDENT MEMBERSHIP. STUDENT MEMBERS ARE NOT PERMITTED TO HOLD OFFICER OR DIRECTOR POSITIONS. FELLOW - ANY MEMBER WHO IS DEEMED TO HAVE MADE A MERITORIOUS CONTRIBUTION TO THE ADVANCEMENT OF HEALTH ECONOMICS AND/OR OUTCOMES RESEARCH AS DEFINED BY THE ISPOR BOARD. NEW PROFESSIONAL - ANY INDIVIDUAL WITH THREE YEARS OR LESS PROFESSIONAL EXPERIENCE IN HEALTH ECONOMICS OR OUTCOMES RESEARCH. RETIRED MEMBERS - ANY MEMBER WITH TEN OR MORE YEARS OF PAID ISPOR MEMBERSHIP AND WORKING LESS THAN HALF TIME (TWENTY OR FEWER HOURS PER WEEK). FORM 990, PART VI, SECTION A, LINE 7A MEMBERS, STUDENT MEMBERS, FELLOWS, NEW PROFESSIONALS, AND RETIRED MEMBERS HAVE THE RIGHT VOTE FOR BOARD OFFICERS AND DIRECTORS. FORM 990, PART VI, SECTION B, LINE 11B THE ISPOR FORM 990 IS PREPARED BY AN INDEPENDENT ACCOUNTING FIRM. THE REVIEW OF THE FORM 990 BEFORE FILING IS DELEGATED TO THE CEO AND EXECUTIVE DIRECTOR BY THE BOARD OF DIRECTORS. THE COMPLETED FORM 990 IS AVAILABLE FOR REVIEW BY THE BOARD OF DIRECTORS AND THE MEMBERSHIP AFTER FILING. FORM 990, PART VI, SECTION B, LINE 12C TO INSURE COMPLIANCE WITH THE ORGANIZATION'S CONFLICT OF INTEREST POLICY, BOARD MEMBERS, OFFICERS AND EMPLOYEES AGREE TO COMPLY WITH THE POLICY BY COMPLETING AND SIGNING A CONFLICT OF INTEREST STATEMENT. EVERY YEAR THE BOARD HAS THE RESPONSIBILITY OF ENSURING COMPLIANCE WITH THE POLICY, ADMINISTERING THE ANNUAL QUESTIONNAIRE AND MAKING DECISIONS AS REQUIRED TO AVOID ACTUAL CONFLICT OF INTEREST. THE BOARD ALSO REVIEWS AND REVISES THIS POLICY AS NEEDED IN THE EVENT OF AN ACTUAL CONFLICT OF INTEREST OR THE APPEARANCE OF A CONFLICT OF INTEREST, INTERESTED PARTY MUST DISCLOSE THE NATURE OF THE CONFLICT AND HE/SHE SHALL NOT BE PRESENT IN THE BOARD OR COMMITTEE DELIBERATIONS OR VOTE ON THE MATTER. COMPLETED CONFLICT OF INTEREST FORMS ARE INCLUDED ON BOARD AGENDAS, AND RECORDED IN THE BOARD MINUTES. FORM 990, PART VI, SECTION B, LINE 15A THE EXECUTIVE COMMITTEE, EXCLUDING THE EXECUTIVE DIRECTOR, CONDUCTS AN ANNUAL REVIEW OF THE EXECUTIVE DIRECTOR'S PERFORMANCE INCLUDING ACCOMPLISHMENTS VERSUS PRE-SPECIFIED GOALS AS WELL AS THE PERFORMANCE OF THE ORGANIZATION. BENCHMARKING OF THE COMPENSATION OF THE EXECUTIVE DIRECTOR IS DETERMINED USING ASSOCIATION CHIEF STAFF EXECUTIVE COMPENSATION SURVEYS BY THE AMERICAN SOCIETY OF ASSOCIATION EXECUTIVES (ASAE). COMPENSATION OF THE EXECUTIVE DIRECTOR IS ALSO DETERMINED WITH THE USE OF COMPENSATION SURVEYS AND THE FORM 990 OF SIMILAR ORGANIZATIONS. THE EXECUTIVE COMMITTEE NEGOTIATES AN EMPLOYMENT AGREEMENT WITH THE EXECUTIVE DIRECTOR AND THEN DETERMINES THE EXECUTIVE DIRECTOR'S COMPENSATION, THROUGH A FORMAL VOTE IN PRIVATE SESSIONS, WITHOUT THE EXECUTIVE DIRECTOR'S PRESENCE. THE FINAL AGREEMENT AND SALARY DETERMINATION IS DOCUMENTED IN A TIMELY COMMUNICATION FROM THE PRESIDENT ON BEHALF OF THE EXECUTIVE COMMITTEE AUTHORIZING THE EXECUTIVE DIRECTOR'S COMPENSATION. THIS COMMUNICATION IS RETAINED WITH THE ISPOR PAYROLL RECORDS. FORM 990, PART VI, SECTION C, LINE 19 ISPOR MAKES ITS FINANCIAL STATEMENTS, CONFLICT OF INTEREST POLICY AND GOVERNING DOCUMENTS AVAILABLE UPON WRITTEN REQUESTS SUBMITTED TO ISPOR'S ADDRESS.